Oligomerix's Grant

Oligomerix raised a round of funding on September 11, 2013. Investors include National Institutes of Health.

Oligomerix is a biopharmaceutical company focused on development of small molecule inhibitors, immunotherapeutic approaches and biomarkers targeting tau oligomers and their newly discovered proteolyti…

Articles about Oligomerix's Grant: